首页|干扰素联合保妇康栓治疗CINⅠ合并HPV感染的临床效果及安全性分析

干扰素联合保妇康栓治疗CINⅠ合并HPV感染的临床效果及安全性分析

扫码查看
目的 分析干扰素联合保妇康栓治疗宫颈上皮内瘤变Ⅰ级(cervical intraepithelial neoplasia grade Ⅰ,CINⅠ)合并人乳头瘤病毒(human papilloma virus,HPV)感染.方法 便利选取2021年1月—2023年1月福建省福清市妇幼保健院收治的72例CINⅠ合并HPV感染患者为研究对象,根据不同的治疗方法分为两组,各36例.对照组采用人干扰素α2b阴道泡腾胶囊治疗,观察组采用人干扰素α2b阴道泡腾胶囊联合保妇康栓治疗.比较两组患者的治疗效果、HPV DNA水平、HPV转阴率和不良反应发生率.结果 治疗后,观察组治疗总有效率为94.44%(34/36),高于对照组的77.78%(28/36),差异有统计学意义(χ2=4.181,P<0.05).治疗1个疗程和治疗3个疗程后,相较对照组,观察组HPV DNA水平更低,差异有统计学意义(P均<0.05).治疗1个疗程和治疗3个疗程后,观察组HPV转阴率为77.78%(28/36)、94.44%(34/36),高于对照组的55.56%(20/36)、77.78%(28/36),差异有统计学意义(χ2=4.000、4.181,P均<0.05).治疗后,观察组的不良反应总发生率低于对照组,差异无统计学意义(P>0.05).结论 临床中针对CINⅠ合并HPV感染患者实施人干扰素α2b阴道泡腾胶囊联合保妇康栓治疗的效果显著,有效地降低HPV DNA水平,并进一步提升患者的HPV转阴率,安全性较高.
Clinical Effect and Safety Analysis of Interferon Combined with Baofu-kang Suppositories in the Treatment of CINⅠ Combined with HPV Infec-tion
Objective To analyze the effect of interferon combined with Baofukang suppository in the treatment of cer-vical intraepithelial neoplasia grade Ⅰ(CINⅠ)with human papillomavirus(HPV)infection.Methods A total of 72 pa-tients with CINⅠ complicated with HPV infection admitted to of Fuqing Maternal and Child Health Care Hospital of Fujian Province from January 2021 to January 2023 were conveniently selected as the research objects.According to different treatment methods,they were divided into two groups,36 cases in each group.The control group was treated with human interferon α2b vaginal effervescent capsule,and the observation group was treated with human interferon α2b vaginal effervescent capsule combined with Baofukang suppository.The therapeutic effect,HPV DNA level,HPV negative conversion rate and the incidence of adverse reactions were compared between the two groups.Results After treatment,the total effective rate of the observation group was 94.44%(34/36),which was higher than 77.78%(28/36)of the control group,and the difference was statistically significant(χ2=4.181,P<0.05).After one course of treatment and three courses of treatment,the HPV DNA level in the observation group was lower than that in the control group,and the difference was statistically significant(both P<0.05).After one course of treatment and three courses of treat-ment,the negative conversion rates of HPV in the observation group were 77.78%(28/36)and 94.44%(34/36),which were higher than those in the control group was 55.56%(20/36)and 77.78%(28/36),and the differences were statisti-cally significant(χ2=4.000,4.181,both P<0.05).After treatment,the total incidence of adverse reactions in the obser-vation group was lower than that in the control group,the difference was not statistically significant(P>0.05).Conclu-sion The clinical treatment of human interferon α2b vaginal effervescent capsule for CINI patients with HPV infection has a significant effect,effectively reducing the HPV DNA level,and further improving the HPV turning rate of pa-tients,with a high safety profile.

Cervical intraepithelial neoplasia grade ⅠHuman papilloma virusHuman interferon α2b vaginal effervescent capsuleBaofukang suppositories

林珠芳、徐爱瑜

展开 >

福建省福清市妇幼保健院妇科,福建 福清 350300

宫颈上皮内瘤变Ⅰ级 人乳头瘤病毒 人干扰素α2b阴道泡腾胶囊 保妇康栓

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(32)